blank Quick help
blank Maintenance news
blank News flashes
blank Related links

Extract from the Register of European Patents

EP About this file: EP2331074

EP2331074 - GRANULATES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL PRODUCTS CONTAINING THEM [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.09.2021
Database last updated on 30.04.2025
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024  [2024/41]
Applicant(s)For all designated states
Mylan Inc.
781 Chestnut Ridge Road
Morgantown, WV 26505 / US
[2020/46]
Inventor(s)01 / LI, Boyong
4758 Ridgetop Drive
Morgantown West Virginia 26508 / US
02 / REYNOLDS, Thomas D.
4 Pineview Place
Morgantown West Virginia 26505 / US
 [2011/24]
Representative(s)Elkington and Fife LLP
Prospect House
8 Pembroke Road
Sevenoaks, Kent TN13 1XR / GB
[2020/46]
Application number, filing date09814882.816.09.2009
[2011/24]
WO2009US05153
Priority number, dateUS20080097667P17.09.2008         Original published format: US 97667 P
[2011/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010033179
Date:25.03.2010
Language:EN
[2010/12]
Type: A1 Application with search report 
No.:EP2331074
Date:15.06.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 25.03.2010 takes the place of the publication of the European patent application.
[2011/24]
Type: B1 Patent specification 
No.:EP2331074
Date:11.11.2020
Language:EN
[2020/46]
Search report(s)International search report - published on:US25.03.2010
(Supplementary) European search report - dispatched on:EP21.08.2012
ClassificationIPC:A61K9/16, A61K9/20, A61K31/277
[2012/38]
CPC:
A61K9/2027 (EP,US); A61K31/277 (EP,US); A61K9/2018 (EP,US);
A61K9/2059 (EP,US); A61P35/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2020/46]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:GRANULAT, VERFAHREN ZU SEINER HERSTELLUNG UND PHARMAZEUTISCHE PRODUKTE DAMIT[2011/24]
English:GRANULATES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL PRODUCTS CONTAINING THEM[2011/24]
French:GRANULÉS, LEUR PROCÉDÉ DE PRÉPARATION ET PRODUITS PHARMACEUTIQUES LES CONTENANT[2011/24]
Entry into regional phase22.03.2011National basic fee paid 
22.03.2011Search fee paid 
22.03.2011Designation fee(s) paid 
22.03.2011Examination fee paid 
Examination procedure22.03.2011Examination requested  [2011/24]
18.03.2013Amendment by applicant (claims and/or description)
05.08.2015Communication of intention to grant the patent
02.12.2015Observations by third parties
15.12.2015Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
15.12.2015Fee for grant paid
15.12.2015Fee for publishing/printing paid
15.12.2015Receipt of the translation of the claim(s)
23.12.2015Despatch of a communication from the examining division (Time limit: M06)
06.10.2016Reply to a communication from the examining division
18.11.2016Communication of intention to grant the patent
25.07.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
25.07.2017Receipt of the translation of the claim(s)
21.09.2017Communication of intention to grant the patent
24.05.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
18.06.2018Communication of intention to grant the patent
15.02.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
12.03.2019Communication of intention to grant the patent
07.11.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
29.11.2019Communication of intention to grant the patent
25.06.2020Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
07.09.2020Fee for grant paid
07.09.2020Fee for publishing/printing paid
07.09.2020Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  05.08.2015
Opposition(s)12.08.2021No opposition filed within time limit [2021/42]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
07.09.2020Request for further processing filed
07.09.2020Full payment received (date of receipt of payment)
Request granted
16.09.2020Decision despatched
The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
07.11.2019Request for further processing filed
07.11.2019Full payment received (date of receipt of payment)
Request granted
18.11.2019Decision despatched
The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
15.02.2019Request for further processing filed
15.02.2019Full payment received (date of receipt of payment)
Request granted
27.02.2019Decision despatched
The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
24.05.2018Request for further processing filed
24.05.2018Full payment received (date of receipt of payment)
Request granted
05.06.2018Decision despatched
The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
25.07.2017Request for further processing filed
25.07.2017Full payment received (date of receipt of payment)
Request granted
08.08.2017Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
06.10.2016Request for further processing filed
06.10.2016Full payment received (date of receipt of payment)
Request granted
18.10.2016Decision despatched
Fees paidRenewal fee
08.09.2011Renewal fee patent year 03
25.02.2013Renewal fee patent year 04
12.09.2013Renewal fee patent year 05
12.09.2014Renewal fee patent year 06
28.09.2015Renewal fee patent year 07
27.09.2016Renewal fee patent year 08
21.09.2017Renewal fee patent year 09
06.09.2018Renewal fee patent year 10
30.09.2019Renewal fee patent year 11
29.09.2020Renewal fee patent year 12
Penalty fee
Additional fee for renewal fee
30.09.201204   M06   Fee paid on   25.02.2013
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.09.2009
AT11.11.2020
CY11.11.2020
CZ11.11.2020
DK11.11.2020
EE11.11.2020
FI11.11.2020
HR11.11.2020
LT11.11.2020
LV11.11.2020
MC11.11.2020
MK11.11.2020
MT11.11.2020
NL11.11.2020
PL11.11.2020
RO11.11.2020
SE11.11.2020
SI11.11.2020
SK11.11.2020
SM11.11.2020
TR11.11.2020
BG11.02.2021
NO11.02.2021
GR12.02.2021
IS11.03.2021
PT11.03.2021
[2024/41]
Documents cited:Search[X]WO0142221  (PHARMACIA CORP [US], et al) [X] 1-10,12-17 * page 13, paragraph 2; example - * * page 16, paragraph l - page 17, paragraph 1 *;
 [X]WO2004100944  (SYNTHON BV [NL], et al) [X] 1-11,17 * example - *;
 [X]WO2004110431  (WARNER LAMBERT CO [US], et al) [X] 1-10,17 * example - *;
 [X]US2006222707  (LERNER E I [IL], et al) [X] 1-10,12-17 * example 4 *;
 [X]WO2007011349  (TEVA PHARMA [IL], et al) [X] 1-11,17 * examples 3,4 *;
 [X]EP1889610  (REDDYS LAB LTD DR [IN]) [X] 1-10,12-17* example - *;
 [X]US2008161404  (CARROLL KEVIN JOSEPH [GB], et al) [X] 1-11,17 * paragraphs [0115] - [0116] *;
 [X]WO2008101723  (KRKA [SI], et al) [X] 1-10,12-17 * example - *;
 [X]WO2008104852  (WOCKHARDT RESEARCH CENTER [IN], et al) [X] 12-16 * example 4 *
International search[X]WO2004110431  (WARNER LAMBERT CO [US], et al);
 [X]US2008161404  (CARROLL KEVIN JOSEPH [GB], et al)
otherEP1929997
 JP2008133259
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.